Speaker(s): 

Nicole Middelton PharmD Candidate, Wilkes University - has nothing to disclose.

Moderator(s): 

Christopher DeFrancesco, PharmD, Clinical Pharmacist; Emilie Detweiler PharmD, PGY1 Pharmacy Resident - Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• 1. Identify key updates in the 2025 ADA guidelines
• 2. Discuss management of diabetes in the hospital setting
• 3. Assess diabetes medications for inpatient diabetes management
• 4. Apply guideline directed medication therapy to patients

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christopher DeFrancesco PharmD, RPH, Anil Singh MD, Roop Parlapalli, MD, FHM, FACP, Mary Ellen Berry PA-C, and Carlena Miller CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None